ParaZero Technologies faces a peculiar divergence: its counter-drone technology is winning new contracts and attracting NATO attention, yet the stock has shed 21% in a single week and now trades at $0.55 — triggering a Nasdaq minimum bid compliance notice that gives the company until November 2 to recover.
Short sellers have built a meaningful position here and aren't letting go. Short interest is running at 7.1% of the free float — up sharply from roughly 4.4% at the start of April — even as short shares edged lower this week by about 6%. That one-month build from 4.4% to 7.1% is the real story: bears added aggressively through late April as the stock deteriorated. Borrow availability has tightened with them. At 29.9% of short interest, availability is well inside the "tight" range — meaning for every three shares already borrowed, fewer than one remains free in the lending pool. The borrow itself costs around 9.1% annualised, roughly stable over the past month and a clear sign of sustained short-selling demand rather than a brief speculative spike. The ORTEX short score of 63.7 corroborates the setup: it has held persistently in the low-to-mid 60s throughout May, consistent with a stock under steady, deliberate short pressure.
The fundamental picture pulls in two directions at once. On the positive side, ParaZero demonstrated its DefendAir counter-drone platform to NATO and Romanian officials at the Black Sea Defense and Security Exhibition earlier this week — a meaningful commercial signal as European defence spending accelerates. The company also signed a Romanian reseller agreement in late April and received a new undisclosed defence client purchase order in mid-April. Against that, the Nasdaq compliance notice issued May 8 represents a concrete downside risk: if the stock cannot trade above $1.00 for ten consecutive business days before November, it faces delisting proceedings. With the close at $0.55, that gap is material.
The institutional holder list reinforces the micro-cap fragility. Empery Asset Management — a known distressed and special situations fund — cut its position by roughly 400,000 shares to 282,000 in the quarter to March 31. Xylo Technologies, the largest disclosed holder at around 2.95% of shares, reported no change as of December 2024. Neither provides obvious buying support at current levels.
Earnings history adds another cautionary layer. The last four reported results all produced negative one-day reactions — the worst a 16% drop on March 27. Three of the four also produced negative five-day reactions. The next event is pencilled for August 28.
The question for the coming weeks is whether the DefendAir contract momentum can generate enough revenue visibility to move the compliance needle, or whether the delisting clock and tight borrow availability become the dominant price driver.
See the live data behind this article on ORTEX.
Open PRZO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
